Etoposide (Accord Healthcare Inc.)
Welcome to the PulseAid listing for the Etoposide drug offered from Accord Healthcare Inc.. This Topoisomerase Inhibitor [EPC],Topoisomerase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Accord Healthcare Inc. |
NON-PROPRIETARY NAME: | Etoposide |
SUBSTANCE NAME: | ETOPOSIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Topoisomerase Inhibitor [EPC],Topoisomerase Inhibitors [MoA] |
ROUTE: | INTRAVENOUS |
DOSAGE FORM: | INJECTION |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2015-03-03 |
END MARKETING DATE: | 0000-00-00 |
Etoposide HUMAN PRESCRIPTION DRUG Details:
Item Description | Etoposide from Accord Healthcare Inc. |
LABELER NAME: | Accord Healthcare Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 20(mg/mL) |
START MARKETING DATE: | 2015-03-03 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 16729-114_5b5fb93c-86f2-b007-e053-2991aa0ad683 |
PRODUCT NDC: | 16729-114 |
APPLICATION NUMBER: | ANDA074513 |
Other ETOPOSIDE Pharmaceutical Manufacturers / Labelers: